IMC Chicago’s Arvinas ARVN Stock Holding History

IMC Chicago’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$204K	Sell	19,200 -5,800	-23%	-$71.8K	﹤0.01%	4995
2025 Q4	$297K	Sell	25,000 -28,800	-54%	-$314K	﹤0.01%	3808
2025 Q3	$458K	Buy	53,800 +13,400	+33%	+$102K	﹤0.01%	3229
2025 Q2	$297K	Buy	+40,400	New	+$298K	﹤0.01%	3113

Other funds holding ARVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMC Chicago's ARVN Position: Q1 2026 in Review

IMC Chicago sold out of Arvinas (ARVN) in Q1 2026, closing a stake of 30,219 shares — an estimated $374K sold.

IMC Chicago first reported a position in ARVN in Q1 2025 and held it in 3 quarters. The position peaked at $358K in Q4 2025. 206 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.

IMC Chicago reported no remaining Arvinas position as of Q1 2026 after selling out during the quarter.
IMC Chicago sold 30,219 Arvinas shares in Q1 2026, an estimated $374K.
IMC Chicago first reported a position in Arvinas in Q1 2025 and held it in 3 quarters.
IMC Chicago's Arvinas position peaked at $358K in Q4 2025.
206 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.